N
Neurocrine Biosciences
Publicbiotechnology
📍 San Diego🗓 Est. 1992
Founded
1992
HQ
San Diego
About
Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. It is headquartered in San Diego, California, and led by CEO Kyle Gano as of October 11, 2024. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine (Ingrezza) was approved in the US to treat adults with tardive dyskinesia (TD).
Open Positions(0 roles)
No open positions at the moment. Check back soon!
Browse all remote jobs →Vibe Scores
Community ratings from people who've worked here.
No ratings yet. Be the first to rate this company!